Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. WISTEM2d Professionals

Supporting STEM2D professionals everywhere

At Johnson & Johnson, we aspire to be the employer of choice for top talent in STEM2D fields (Science, Technology, Engineering, Math, Manufacturing, and Design) because we believe STEM2D professionals are powerful catalysts for change in the world.

In our professional programs, we champion the power of perspective through reimagined attraction and development of the world’s best STEM2D talent.
Johnson & Johnson research scientists collaborating in lab setting

Why WiSTEM2D matters to us

  • Johnson & Johnson was founded on science and innovation and we’re committed to being a partner and advocate for all STEM2D students and professionals. We are enthusiastic about working with esteemed institutions and organizations to expand the idea base in STEM2D fields and fostering many perspectives across the world.
    Kathy Wengel
    Executive Vice President & Chief Technical Operations & Risk Officer

More from Johnson & Johnson

How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health

Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.

“Patients are the center of everything": Meet the scientist leader dedicated to developing effective IBD treatments

Her natural curiosity, determination and fascination with science inspired Esi Lamousé, M.D., Ph.D., to pursue a career that’s helped bring innovative therapies for inflammatory bowel disease to patients in need around the world.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.